Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ribosomal Protein L10a Inhibitors

Ribosomal Protein L10a Inhibitors belong to a specific chemical class of compounds that are characterized by their ability to target and inhibit the activity of the ribosomal protein L10a. Ribosomal proteins are essential components of ribosomes, the cellular organelles responsible for protein synthesis. L10a is a crucial protein that plays a pivotal role in the assembly and functioning of the ribosome. By specifically targeting this protein, the inhibitors disrupt the normal ribosomal machinery, leading to interference with protein synthesis within the cell.

The mechanism of action of Ribosomal Protein L10a Inhibitors involves binding to the L10a protein, which results in the distortion of its native conformation or interaction with other ribosomal components. As a consequence, this disruption affects the ribosomal subunit's stability or alters its ability to catalyze the translation process, thereby impeding protein synthesis. Inhibition of protein synthesis can have significant implications for various cellular functions and processes, as proteins are essential molecules involved in almost every aspect of cellular life. Researchers have been exploring the potential of Ribosomal Protein L10a Inhibitors as valuable tools for understanding ribosomal biology and cellular processes. These inhibitors have been utilized extensively in laboratory settings to study the impact of perturbing protein synthesis and unravel the intricate workings of ribosomes. Furthermore, the study of these inhibitors aids in deciphering the ribosomal assembly process, its dynamic nature, and its role in cellular regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CX-5461

1138549-36-6sc-507275
5 mg
$245.00
(0)

A small molecule inhibitor that specifically targets the ribosomal DNA transcription.

BMH-21

896705-16-1sc-507460
10 mg
$165.00
(0)

A synthetic small molecule compound that disrupts ribosomal biogenesis, leading to selective killing of cancer cells.

Sangivamycin

18417-89-5sc-204261
sc-204261A
sc-204261B
sc-204261C
sc-204261D
sc-204261E
1 mg
10 mg
25 mg
50 mg
100 mg
250 mg
$333.00
$1348.00
$2611.00
$5212.00
$9894.00
$20298.00
(1)

An anticancer and antiviral agent that interferes with the ribosomal protein synthesis process.